CD276 and neoplasm: Because Signal 2 activation without Signal 1 is thought to be immunologically inert, we reasoned that a B7-H3–targeted costimulatory antibody would enhance TIL-mediated immunity yet avoid deleterious on-target off-tumor (OTOT) effects likely problematic for other B7-H3–targeted therapies.